Connection

David Gutman to Substance-Related Disorders

Back to Details
This is a "connection" page, showing publications David Gutman has written about Substance-Related Disorders.
David Gutman
Connection Strength
0.009
Substance-Related Disorders
  1. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology (Berl). 2007 Jun; 192(3):385-96.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.